News
-
-
-
-
-
PRESS RELEASE
Just – Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
Just - Evotec Biologics partners with BARDA to optimize biomanufacturing of antibodies against Ebola & related viruses, strengthening U.S. government response capabilities -
-
-
PRESS RELEASE
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
Evotec receives $10 M milestone from Bristol Myers Squibb for Phase 1 clinical study initiation of BMS-986506 in clear cell renal cell carcinoma. Collaboration focuses on protein degradation for cancer treatment -
-
